131
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

CXCL16 is a surrogate marker of inflammatory bowel disease

, MD, , , MD, , , , , , & show all
Pages 283-288 | Received 20 Jun 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdullah Tok, Muhammet Seyithanoğlu, Alev Ozer, Uğurkan Erkayıran, Selim Karaküçük & Ahmet Çelebi. (2021) The serum level of soluble CXCL16 is increased in preeclampsia and associated with hepatic/renal damage. The Journal of Maternal-Fetal & Neonatal Medicine 34:9, pages 1435-1440.
Read now
HE Gruber, E Marrero, JA Ingram, GL Hoelscher & EN Hanley$suffix/text()$suffix/text(). (2017) The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro. Biotechnic & Histochemistry 92:1, pages 7-14.
Read now

Articles from other publishers (19)

Nagisa Nosrati, Marica Bakovic & Gopinadhan Paliyath. (2017) Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds. International Journal of Molecular Sciences 18:10, pages 2050.
Crossref
Dorota Pawlica-Gosiewska, Bogdan Solnica, Katarzyna Gawlik, Dorota Cibor, Tomasz Mach, Danuta Fedak & Danuta Owczarek. (2017) The use of selected neutrophil protein plasma concentrations in the diagnosis of Crohn’s disease and ulcerative colitis – a preliminary report. Postępy Higieny i Medycyny Doświadczalnej 71:1, pages 0-0.
Crossref
Kek Heng Chua, Jin Guan Ng, Ching Ching Ng, Ida Hilmi, Khean Lee Goh & Boon Pin Kee. (2016) Association of NOD1 , CXCL16 , STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohn’s disease . PeerJ 4, pages e1843.
Crossref
XIAOWEN YU, RENPING ZHAO, SENSEN LIN, XIANSHU BAI, LUYONG ZHANG, SHENGTAO YUAN & LI SUN. (2016) CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1α in human umbilical vein endothelial cells. Oncology Reports 35:3, pages 1557-1565.
Crossref
Marko Kalliomäki, Seija Rajala, Heidi Elamo, Merja Ashorn & Tarja Ruuska. (2014) Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitis. Journal of Crohn's and Colitis 8:10, pages 1222-1226.
Crossref
Francesca Turroni, Valentina Taverniti, Patricia Ruas-Madiedo, Sabrina Duranti, Simone Guglielmetti, Gabriele Andrea Lugli, Laura Gioiosa, Paola Palanza, Abelardo Margolles, Douwe van Sinderen & Marco Ventura. (2014) Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response. Applied and Environmental Microbiology 80:2, pages 730-740.
Crossref
Madhavi Rayapudi, Priya Rajavelu, Xiang Zhu, Ajay Kaul, Rituraj Niranjan, Scott Dynda, Akanksha Mishra, Jochen Mattner, Asifa Zaidi, Parmesh Dutt & Anil Mishra. (2014) Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clinical & Translational Immunology 3:1, pages e9.
Crossref
Øystein Brenna, Marianne W. Furnes, Ignat Drozdov, Atle van Beelen Granlund, Arnar Flatberg, Arne K. Sandvik, Rosalie T. M. Zwiggelaar, Ronald Mårvik, Ivar S. Nordrum, Mark Kidd & Björn I. Gustafsson. (2013) Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBD. PLoS ONE 8:1, pages e54543.
Crossref
Anna Vaiopoulou, Maria Gazouli, George Theodoropoulos & George Zografos. (2012) Current Advantages in the Application of Proteomics in Inflammatory Bowel Disease. Digestive Diseases and Sciences 57:11, pages 2755-2764.
Crossref
Radu M. Nanau & Manuela G. Neuman. (2012) Metabolome and inflammasome in inflammatory bowel disease. Translational Research 160:1, pages 1-28.
Crossref
Paul Henderson, Aoife Casey, Sally J Lawrence, Nicholas A Kennedy, Kathleen Kingstone, Pam Rogers, Peter M Gillett & David C Wilson. (2012) The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease. American Journal of Gastroenterology 107:6, pages 941-949.
Crossref
T. Ueland, L.M. Smedbakken, J. Hallén, D. Atar, J.L. Januzzi, B. Halvorsen, J.K. Jensen & P. Aukrust. (2012) Soluble CXCL16 and long-term outcome in acute ischemic stroke. Atherosclerosis 220:1, pages 244-249.
Crossref
Hua Zhang, Ming Fan & Gopinadhan Paliyath. 2011. Functional Foods, Nutraceuticals, and Degenerative Disease Prevention. Functional Foods, Nutraceuticals, and Degenerative Disease Prevention 213 233 .
S. E. Levison, J. T. McLaughlin, L. A.H. Zeef, P. Fisher, R. K. Grencis & J. L. Pennock. (2010) Colonic transcriptional profiling in resistance and susceptibility to trichuriasis. Inflammatory Bowel Diseases 16:12, pages 2065-2079.
Crossref
Julia Diegelmann, Julia Seiderer, Jan-Hendrik Niess, Dirk Haller, Burkhard Göke, Hans-Christian Reinecker & Stephan Brand. (2010) Expression and regulation of the chemokine CXCL16 in Crohnʼs disease and models of intestinal inflammation. Inflammatory Bowel Diseases 16:11, pages 1871-1881.
Crossref
Ke-di Wang, Zhi-zhong Liu, Rui-min Wang, Ya-jie Wang, Guo-jun Zhang, Jian-rong Su & Xi-xiong Kang. (2010) Chemokine CXC Ligand 16 serum concentration but not A181V genotype is associated with atherosclerotic stroke. Clinica Chimica Acta 411:19-20, pages 1447-1451.
Crossref
Changcun Guo, Fangfang Yao, Kaichun Wu, Liping Yang, Xin Zhang & Jie Ding. (2010) Chromatin immunoprecipitation and association study revealed a possible role of Runt-related transcription factor 3 in the ulcerative colitis of Chinese population. Clinical Immunology 135:3, pages 483-489.
Crossref
KOICHI YANABA, EIJI MUROI, AYUMI YOSHIZAKI, TOSHIHIDE HARA, FUMIHIDE OGAWA, KAZUHIRO SHIMIZU, MARIKO YOZAKI, MINORU HASEGAWA, MANABU FUJIMOTO, KAZUHIKO TAKEHARA & SHINICHI SATO. (2009) Serum CXCL16 Concentrations Correlate with the Extent of Skin Sclerosis in Patients with Systemic Sclerosis. The Journal of Rheumatology 36:9, pages 1917-1923.
Crossref
Xuhang Li, Laurie Conklin & Philip Alex. (2008) New serological biomarkers of inflammatory bowel disease. World Journal of Gastroenterology 14:33, pages 5115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.